About the Authors

Thorgerdur Palsdottir

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft

thorgerdur.palsdottir@ki.se

Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Tobias Nordström

Roles Conceptualization, Writing – review & editing

Affiliations Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden

Markus Aly

Roles Conceptualization, Writing – review & editing

Affiliations Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Urology, Karolinska University Hospital Solna, Stockholm, Sweden

Johan Lindberg

Roles Conceptualization, Writing – review & editing

Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Mark Clements

Roles Conceptualization, Methodology, Writing – review & editing

Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Lars Egevad

Roles Conceptualization, Writing – review & editing

Affiliation Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Henrik Grönberg

Roles Funding acquisition, Supervision, Writing – review & editing

Affiliations Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Oncology, Capio St Görans Sjukhus, Stockholm, Sweden

Martin Eklund

Roles Conceptualization, Data curation, Funding acquisition, Methodology, Supervision, Writing – review & editing

Affiliation Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Competing Interests

We declare the following competing interests: Henrik Grönberg has five prostate cancer diagnostic related patents pending, has patent applications licensed to Thermo Fisher Scientific, and might receive royalties from sales related to these patents. Martin Eklund is named on four of these five patent applications. Karolinska Institutet collaborates with Thermo Fisher Scientific in developing the technology for the Stockholm3 prostate cancer diagnostic prediction model(1. PROGNOSTIC METHOD FOR INDIVIDUALS WITH PROSTATE CANCER. Publication info:WO2014079874 (A1)2014-05-30; 2. METHOD FOR INDICATING A PRESENCE OR NON-PRESENCE OF AGGRESSIVE PROSTATE CANCER, Publication info:WO2014079865 (A1)2014-05-30; 3. METHOD FOR INDICATING A PRESENCE OR NON-PRESENCE OF PROSTATE CANCER IN INDIVIDUALS WITH PARTICULAR CHARACTERISTICS, Publication info:WO2018141828 (A1)2018-08-09; 4. METHOD FOR DETECTING A SOLID TUMOR CANCER, Publication info: WO2015137870 (A1)2015-09-17; 5. METHOD FOR INDICATING THE PRESENCE OR NON-PRESENCE OF PROSTATE CANCER, Publication info: WO2013172779 (A2)2013-11-21). Other authors declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.